An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer Gert RijksenSabrina S. Adriaansen-SlotGerard E. J. Staal Report Pages: 139 - 145
Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cellsin vitro andin vivo Philippe RostagnoJean-Louis MollCyril Caldani Report Pages: 147 - 154
Advanced breast cancer: A randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine J. A. GreenA. J. SlaterV. Kelly Report Pages: 155 - 163
Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: Correlation to tumor stage and long-term survival Dietmar ÖfnerBert BierKurt W. Schmid Report Pages: 165 - 176
Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections Taiping ChenKapil DhingraC. Marcelo Aldaz Report Pages: 177 - 185
Postsynthetic regulation of insulin-like growth factor-binding protein-3 by MCF-7 human breast cancer cells in culture Randall W. GrimesAndrea ManniJames M. Hammond Report Pages: 187 - 196
Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction V. GopalkrishnaU. R. SinghB. C. Das Report Pages: 197 - 202
FISH detection of HER-2/neu oncogene amplification in early onset breast cancer Wei-Rong XingKennedy W. GilchristLorraine F. Meisner Report Pages: 203 - 212
Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis Ulf LönnSigrid LönnBjörn Stenkvist Report Pages: 213 - 220
Cathepsins D, B, and L in transformed human breast epithelial cells Tamara T. LahGloria CalafIerachmiel Daskal Report Pages: 221 - 233
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer Lazzaro RepettoPier Giorgio GiannessiRiccardo Rosso Report Pages: 235 - 238
Endoglin/CD 105 may not be an optimal tumor endothelial treatment target Arjan W. GriffioenCora A. DamenGerard Groenewegen Letter to the editor Pages: 239 - 240
Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target Philip E. ThorpeFrancis J. Burrows Letter to the editor Pages: 241 - 242